Market Overview:
The global retinoid treatment for skin market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of skin disorders, rising awareness about the benefits of retinoid treatment, and technological advancements in the field of dermatology. The global retinoid treatment for skin market can be segmented on the basis of type into over-the-counter (OTC) and prescription medicines. The OTC segment is expected to account for a larger share of the market than the prescription medicine segment during the forecast period. This can be attributed to factors such as lower cost and easy availability compared with prescription medicines. On the basis of application, the global retinoid treatment for skin market can be divided into topical and oral applications. The topical application segment is expected to account for a larger share of this market than oral applications during 2018–2030 owing to its higher adoption rates due various advantages such as ease-of-use, no systemic side effects, etc.
Product Definition:
A retinoid is a type of vitamin A derivative that is used in skin care products to treat a variety of skin conditions, including wrinkles, acne, and psoriasis. Retinoids work by promoting cell turnover and collagen production, which helps to improve the appearance of the skin. Retinoid treatment for skin is important because it can help to reduce the signs of aging, clear up acne breakouts, and improve the texture of the skin.
OTC:
OTC stands for Over-the-Counter and is a market segment that caters to all the needs of consumers without the need for medical prescription. OTC products are usually available in small quantities, as they do not require a physician’s prescription. Most OTC medications are sold in drug stores without a prescription; however, some drugs such as cough syrups require a doctor’s approval before selling them over the counter.
Prescription Medicine:
Prescription medicine is a category of medical products which are regulated by the FDA. Prescription medicines include OTC drugs as well as over-the-counter (OTC) drugs. The major difference between OTC and prescription medicines is that while the former can be used for immediate relief from symptoms, the latter are prescribed by doctors for a particular disease or condition.
Retinoids have been studied extensively in clinical trials.
Application Insights:
Based on the application, the market is segmented into topical retinoids and oral retinoids. The topical segment dominated the market in 2017 owing to its non-invasive treatment method and high efficacy in comparison with other treatments such as laser or surgery. Furthermore, increasing R&D activities for developing new products for different skin types is expected to boost product demand over the forecast period. For instance, in January 2018, Galderma Laboratories received FDA approval for Restylane Silk as the first hyaluronic acid dermal filler via cannula system that does not require a surgical incision.
The oral segment is anticipated to witness significant growth over the forecast period due to increasing product usage among patients who failed with other treatment methods such as phototherapy and surgery for acne scars or wrinkles removal.
Regional Analysis:
Asia Pacific is expected to be the fastest-growing regional market over the forecast period. The presence of a large target population and increasing awareness about advanced therapies for skin care are anticipated to drive growth in this region. In addition, rising disposable income levels and growing consumer spending on premium cosmetics are also likely to contribute toward market growth during the forecast period.
In 2016, Japan held a significant share in global retinoid treatment for skin OTC sales owing to high demand from women aged 25 years and above suffering from photoaging or acne scarring problems due to sun exposure or other causes such as smoking & alcohol consumption etc. Moreover, increasing R&D activities by key players coupled with new product launches is further expected to fuel industry expansion over the next eight years.
Growth Factors:
- Increasing incidence of skin disorders such as acne, psoriasis, and eczema is expected to drive the demand for retinoid treatment products over the forecast period.
- Rising awareness about the benefits of retinoid treatment is anticipated to boost market growth.
- Growing use of retinoids in anti-aging products is projected to fuel market demand over the next few years.
- Increasing R&D investments for novel formulations and delivery systems are likely to provide opportunities for market growth in the near future. 5) Technological advancements in product formulation are expected to propel Retinoid Treatment for Skin Market growth during the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Retinoid Treatment for Skin Market Research Report
By Type
OTC, Prescription Medicine
By Application
Topical, Oral
By Companies
Galderma, Bausch Health, Teva, GlaxoSmithKline, Mylan, Almirall, Sun Pharma, Mayne Pharma, Lion, HUAPONT, Sine Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
150
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Retinoid Treatment for Skin Market Report Segments:
The global Retinoid Treatment for Skin market is segmented on the basis of:
Types
OTC, Prescription Medicine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Topical, Oral
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Galderma
- Bausch Health
- Teva
- GlaxoSmithKline
- Mylan
- Almirall
- Sun Pharma
- Mayne Pharma
- Lion
- HUAPONT
- Sine Pharma
Highlights of The Retinoid Treatment for Skin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- OTC
- Prescription Medicine
- By Application:
- Topical
- Oral
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Retinoid Treatment for Skin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Retinoids are a type of medication that is used to treat skin conditions. They work by reducing the amount of oil and inflammation in the skin. This can help improve the appearance of your skin, and make it less likely to develop new problems.
Some of the key players operating in the retinoid treatment for skin market are Galderma, Bausch Health, Teva, GlaxoSmithKline, Mylan, Almirall, Sun Pharma, Mayne Pharma, Lion, HUAPONT, Sine Pharma.
The retinoid treatment for skin market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Retinoid Treatment for Skin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Retinoid Treatment for Skin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Retinoid Treatment for Skin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Retinoid Treatment for Skin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Retinoid Treatment for Skin Market Size & Forecast, 2020-2028
4.5.1 Retinoid Treatment for Skin Market Size and Y-o-Y Growth
4.5.2 Retinoid Treatment for Skin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 OTC
5.2.2 Prescription Medicine
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Topical
6.2.2 Oral
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Retinoid Treatment for Skin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Retinoid Treatment for Skin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 OTC
9.6.2 Prescription Medicine
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Topical
9.10.2 Oral
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 OTC
10.6.2 Prescription Medicine
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Topical
10.10.2 Oral
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 OTC
11.6.2 Prescription Medicine
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Topical
11.10.2 Oral
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 OTC
12.6.2 Prescription Medicine
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Topical
12.10.2 Oral
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 OTC
13.6.2 Prescription Medicine
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Topical
13.10.2 Oral
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Retinoid Treatment for Skin Market: Competitive Dashboard
14.2 Global Retinoid Treatment for Skin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Galderma
14.3.2 Bausch Health
14.3.3 Teva
14.3.4 GlaxoSmithKline
14.3.5 Mylan
14.3.6 Almirall
14.3.7 Sun Pharma
14.3.8 Mayne Pharma
14.3.9 Lion
14.3.10 HUAPONT
14.3.11 Sine Pharma
